FDA NDC Directory · JSON-LD · Markdown

buprenorphine hydrochloride and naloxone hydrochloride dihydrate

NDC 0904-7010 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerMajor Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA203326
Dosage form / routeTABLET · SUBLINGUAL
Active ingredientsBUPRENORPHINE HYDROCHLORIDE (8 mg/1)
NALOXONE HYDROCHLORIDE DIHYDRATE (2 mg/1)
Marketing started20140627
Package count1

External sources

Source: openFDA. Public-domain (CC0).